Conditions: Uterine Cervical Cancer
Keywords: Cervical Carcinoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: no

Brief summary:
The purpose of this study is first to establish what is the ideal dose of gemcitabine, a chemotherapy agent, when given in combination with radiation. In addition, the investigators want to determine the side effects and the effectiveness of this combination. The investigators will also study several markers to try to identify markers or tests that will predict which patients will benefit more from this treatment.

Detailed description:

Arms:
arm 1: Gemcitabine 350 mg/m2 IV weekly x 6 weeks with concurrent external radiation

Interventions: intervention 1: Gemcitabine
Intervention descriptions: intervention 1: Gemcitabine weekly x 6 wks with concurrent external radiation

Protocol document: